Riskpilot← Back to searchSign inGet full accessRegnér Ortopedi AB
ABActiveOrg 5566982350Burgårdsgatan 14General medical practice activities · NACE 8621Est. 20061 employees
Revenue 2025
SEK 0
EBITDA margin
—
+90% vs 2024
Equity ratio
62.7%
Financial strength
Net profit 2025
SEK 438K
+35% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -65K | +90% |
| Net profit | SEK 438K | +35% |
| Total assets | SEK 3,3M | -3% |
| Equity | SEK 2,1M | +8% |
| Employees | 1 | — |
Legal name
Regnér Ortopedi AB
Org number
5566982350
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
9 februari 2006
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva medicinsk diagnostik och behandling, förebyggande friskvård, utbildning, forskning och produktutveckling inom hälso- och sjukvård, äga och förvalta värdepapper samt att idka därmed förenlig verksamhet.
Address
Burgårdsgatan 14
Email
lasse.regner@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −610 | −480 | −479 | −621 | −65 |
| Depreciation & amort. | −12 | −12 | −0 | −0 | −0 |
| EBIT | −622 | −492 | −479 | −621 | −65 |
| Net financials | 1 361 | 124 | 914 | 980 | 605 |
| Profit before tax | 661 | 25 | 585 | 419 | 560 |
| Tax | −124 | −64 | −77 | −95 | −122 |
| Net profit | 537 | −39 | 508 | 324 | 438 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 561 | 3 180 | 3 345 | 3 438 | 3 321 |
| Equity | 2 070 | 1 767 | 1 874 | 1 937 | 2 083 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 233 | 295 | 503 | 593 | 350 |
| Total debt | 233 | 295 | 503 | 593 | 350 |
EBITDA margin
-6500000.0%
This company
15.8%
Market median
-41139341% vs market
20212025
Equity ratio
62.7%
This company
38.2%
Market median
+64% vs market
20212025
Return on equity
21.0%
This company
18.4%
Market median
+14% vs market
20212025
Net profit margin
43800000.0%
This company
8.1%
Market median
+540740641% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
KG Audit | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Regnér Ortopedi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjell Göran Carlsson | Audit | 0 companies |
| Lars Reinhold Regnér | Board of Directors | 0 companies |
| Ulla Annika Wolfbrandt | Deputy Board Member | 0 companies |